Cardiovasc Pharmacol
Data from a Chinese cohort also identified an increased risk for preeclampsia in patients with hepatic steatosis and normal BMI, supporting an independent role of MASLD that cannot be explained by residual confounding by weight (64)
318, n o 15, 1460 (ISSN 0098-7484, PMID 29049653, PMCID 5817971, DOI 10.1001/jama.2017.14752, lire en ligne, consult le (en) Mansur Shomali, Optimizing the Care of Patients With Type 2 Diabetes Using Incretin-Based Therapy: Focus on GLP-1 Receptor Agonists , Clinical Diabetes , vol
Newer agents, particularly semaglutide and tirzepatide, can produce weight loss exceeding 15% of body weight in the general population, raising hopes that they may offer a more effective solution for people with SSDs